Seniors on common maintenance drugs face fewer COVID-19 risks, NIH study finds
By
Alicia Lasek
Apr 20, 2022
Drugs used regularly in the long-term care population may help prevent SARS-CoV-2 infection and poor COVID-19 outcomes, investigators say.
Fixed-dose combo pill cuts older adults’ stroke risk by more than half
By
Alicia Lasek
Aug 31, 2021
A combination of aspirin, statins and at least two blood pressure drugs can be given separately or as a polypill, investigators say. Benefits were seen with different blood pressure levels, cholesterol...
Less popular hypertension drug has fewer side effects, study finds
By
Alicia Lasek
Jul 28, 2021
Two common choices for treating high blood pressure do a good job of preventing related cardiovascular events. But one drug class is less associated with swelling, cough, pancreas inflammation and gastrointestinal...
After decade of progress, diabetes control loses steam as first-line therapies go underused
By
Alicia Lasek
Jun 11, 2021
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Even in people with normal blood pressure, meds reduce adverse heart events
By
Alicia Lasek
May 03, 2021
Treatment with blood pressure-lowering medications should be a cornerstone of cardiovascular risk prevention — and not based solely on prior history of cardiovascular disease or blood pressure status,...
Polypill plus aspirin leads to fewer cardiovascular events, study finds
By
Alicia Lasek
Nov 17, 2020
Adults who took a daily combination pill containing statins and blood-pressure–lowering drugs, plus daily aspirin, were less likely to experience heart attack, stroke, and death from cardiovascular causes.
Clinical briefs for Thursday, Oct. 15
By
Alicia Lasek
Oct 15, 2020
CDC updates COVID vaccine information for healthcare workers … Mild-to-moderate COVID-19 ‘highly unlikely’ to be infectious after day 10: study … Certain blood pressure meds tied to lower mortality...
Low-dose blood thinner prevents stroke in elderly with atrial fibrillation, trial finds
By
Alicia Lasek
Sep 08, 2020
Patients over age 80 who were not candidates for standard anticoagulant doses due to bleeding risk experienced fewer blood clots and strokes with a low daily dose of the drug edoxaban.
Clinical briefs for Tuesday, September 1
By
Alicia Lasek
Sep 01, 2020
No link between high blood pressure drugs and cancer, large study finds … FDA chief: Any early COVID vaccine approval will be a ‘science, medicine, data decision’ … Navigation problems may be an...
Clinical briefs for Tuesday, Aug. 25
By
Alicia Lasek
Aug 25, 2020
Assisted living could be next in line for COVID relief funds … Condition that mimics dementia gets its own diagnostic criteria … Black elders use hospice less, undergo more intensive treatment...